CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 35,593 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02989103
NCT02989103N/ACompleted

Hyperthyroid Follow-Up Study

National Cancer Institute (NCI)·observational·Posted Dec 12, 2016·Updated Oct 29, 2020

In Brief

An observational study for All-Cause Mortality and 2 related conditions. Completed, enrolled 35,593 participants across 1 site.

Detailed Summary

Background: Hyperthyroidism is a common disease. It is very common for women. It is usually treated with Radioiodine (I-131). Some people think that this might cause cancer, even many years later. Past studies of people with hyperthyroidism have not been clear about cancer risks after I-131. Researchers want to look at a group of people with the disease who got I-131 many years ago. They want to look at how their health was months and years later. Objective: To learn more about disease risks in relation to radiation from I-131 treatment for hyperthyroidism. Eligibility: People who were part of the previous study. These are people who were diagnosed with hyperthyroidism at U.S. and U.K. hospitals from 1946 to 1964. About 95% of the participants have already died. Design: Researchers will examine data already collected by the past study. This includes data on participants later cancers and other health outcomes after they had I-131 treatment. Researchers will compare that data to a National Death Index search. This was already done for data up through 2003. This study will cover 2004 2014. Researchers will not be in touch with study participants or their next of kin....

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedDec 12, 2016
Enrollment StartDec 6, 2016
Primary CompletionSep 1, 2020
Study CompletionOct 28, 2020
TodayJul 2, 2026
Enrollment to primary: 3.7 yearsPosted 9.6 years ago